Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
China
Western Pacific
Clear all
Type of publications
NITAG documentation
(15)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(47)
Topics
Available to download in languages
Regions
Western Pacific
(64)
South-East Asia
(1)
Countries
China
(64)
Australia
(100)
Japan
(3)
Mongolia
(1)
New Zealand
(10)
South Korea
(8)
Diseases
COVID-19
(26)
Haemophilus influenzae type B
(1)
Hepatitis A
(3)
Hepatitis B
(4)
Human papillomavirus (HPV)
(6)
Influenza
(7)
Mumps
(1)
Pneumococcal disease
(7)
Rabies
(1)
Rotavirus
(1)
Varicella
(2)
Vaccine topics
Target population
Publication date
64 results found
2022
∙
Shao, W. Chen, X. Zheng, C. Wang, G. Zhang, B. Zhang, W.
Pneumococcal vaccination coverage and willingness in mainland China
2022
∙
Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.
Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
2021
∙
Cheng, S. Zhao, Y. Wang, F. Chen, Y. Kaminga, A. C. Xu, H.
Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis
2021
∙
Hoang, T. Anh, T. T. T.
Comparison of comorbidities in relation to critical conditions among coronavirus disease 2019 patients: A network meta-analysis
2021
∙
Shi, W. Cheng, X. Wang, H. Zang, X. Chen, T.
Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
2021
∙
Li, W. Liu, S. Qian, S. Zhu, J. Selvaraj, J. N. Zhang, X.
Is the rate of adverse reaction to rabies vaccine in China really as the public thinks?—based on a meta analysis
2021
∙
Yin, T. Li, Y. Ying, Y. Luo, Z.
Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors
2021
∙
Yang, X. Zhao, H. Li, Z. Zhu, A. Ren, M. Geng, M. Li, Y. Qin, Y. Feng, L. Peng, Z. An, Z. Zheng, J. Li, Z. Feng, Z.
Review influenza vaccine effectiveness in mainland china: A systematic review and meta-analysis
2021
∙
Li, Y. Wang, H. Furnback, W. Wang, B. C. M. Zhu, S. Dong, P.
The cost-effectiveness of 13-valent pneumococcal conjugate vaccine in seven Chinese cities
2021
∙
Zhang, Z. Suo, L. Pan, J. Zhao, D. Lu, L.
Two-dose varicella vaccine effectiveness in China: a meta-analysis and evidence quality assessment
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register